Assessment of medication adherence in patients with Type 2 Diabetes and arterial hypertension: medication adherence in chronic disease
Autor(a) principal: | |
---|---|
Data de Publicação: | 2024 |
Outros Autores: | , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | https://doi.org/10.51126/revsalus.v6i1.594 |
Resumo: | Aims: Assessment of medication adherence in newly diagnostic and treated patients with Type 2 Diabetes Mellitus and Arterial Hypertension, in the Primary Health Care Units of Lisbon and Tagus Valley. Methods: This is an observational and retrospective cohort study. The population is composed of newly diagnosed patients with Type 2 Diabetes Mellitus and Arterial Hypertension, at the beginning of treatment. Data was extracted from the Lisbon and Tagus Valley Regional Health Administration Information System. Medication adherence was assessed in three periods: patients started therapy or not after the professional's prescription (initiation); medication possession rate during the follow-up period (MPR) (implementation) and medication discontinuation, marks the end of therapy (discontinuation). Results: An initiation rate of 84.2% was obtained in patients with both diseases (98% for oral antidiabetic therapy and 84.6% for antihypertensive therapy). The implementation rates (MPR) for both diseases was only 3.4% (4.2% were considered adherent to oral antidiabetic therapy and 8.5% to antihypertensive therapy). The discontinuation rate was 3.4% (5.5% for oral antidiabetic therapy and 13.2% for antihypertensive therapy). Most patients initiate taking drugs after prescription but very few patients have a MPR enough to consider them having good adherence. Moreover, few patients discontinue the medication. Conclusions: Patients had a higher implementation rate to antihypertensive therapy but, on the other hand, were more persistent to the oral antidiabetic therapy. Through this new assessment, the medication adherence pattern seems to be influenced by the patient and by the disease itself. |
id |
RCAP_9b5b203447aa5920fc6e85b15d37d239 |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/594 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Assessment of medication adherence in patients with Type 2 Diabetes and arterial hypertension: medication adherence in chronic diseaseAvaliação da adesão à terapêutica em doentes com Diabetes Tipo 2 e hipertensão arterial: Adesão à medicação nas doenças crónicasArterial Hypertensionchronic diseaseinitiationmedication adherencepersistencetype 2 diabetes mellitusHipertensão Arterialdoença crónicainiciaçãoadesão à terapêuticapersistênciaDiabetes Mellitus tipo 2Aims: Assessment of medication adherence in newly diagnostic and treated patients with Type 2 Diabetes Mellitus and Arterial Hypertension, in the Primary Health Care Units of Lisbon and Tagus Valley. Methods: This is an observational and retrospective cohort study. The population is composed of newly diagnosed patients with Type 2 Diabetes Mellitus and Arterial Hypertension, at the beginning of treatment. Data was extracted from the Lisbon and Tagus Valley Regional Health Administration Information System. Medication adherence was assessed in three periods: patients started therapy or not after the professional's prescription (initiation); medication possession rate during the follow-up period (MPR) (implementation) and medication discontinuation, marks the end of therapy (discontinuation). Results: An initiation rate of 84.2% was obtained in patients with both diseases (98% for oral antidiabetic therapy and 84.6% for antihypertensive therapy). The implementation rates (MPR) for both diseases was only 3.4% (4.2% were considered adherent to oral antidiabetic therapy and 8.5% to antihypertensive therapy). The discontinuation rate was 3.4% (5.5% for oral antidiabetic therapy and 13.2% for antihypertensive therapy). Most patients initiate taking drugs after prescription but very few patients have a MPR enough to consider them having good adherence. Moreover, few patients discontinue the medication. Conclusions: Patients had a higher implementation rate to antihypertensive therapy but, on the other hand, were more persistent to the oral antidiabetic therapy. Through this new assessment, the medication adherence pattern seems to be influenced by the patient and by the disease itself.Objetivos: Avaliação da adesão à terapêutica em doentes recém-diagnosticados com Diabetes Mellitus tipo 2 e Hipertensão Arterial, nos Cuidados de Saúde Primários na Região Lisboa Vale Tejo. Metodologia: Estudo observacional de coorte retrospetivo. População composta pelos doentes recém-diagnosticados com Diabetes Mellitus tipo 2 e Hipertensão Arterial, em início de tratamento. Os dados foram extraídos do Sistema de Informação da Administração Regional de Saúde de Lisboa Vale Tejo. A adesão à terapêutica foi avaliada nas suas três componentes: se os doentes iniciaram a terapêutica prescrita (iniciação); através do Medication Possession Ratio (MPR) durante o período de seguimento (implementação) e a descontinuação da medicação, que marca o fim do tratamento (descontinuação). Resultados: A taxa de iniciação foi de 84.2% nos doentes com ambas as doenças (98% para a terapêutica antidiabética oral e 84.6% para a terapêutica anti-hipertensiva). A taxa de implementação (MPR) para ambas as doenças foi de, apenas 3.4% (4.2% foram considerados aderentes com a terapêutica antidiabética oral e 8.5% para a terapêutica anti-hipertensiva). A taxa de descontinuação foi de 3.4% (5.5% para a terapêutica antidiabética oral e 13.2% para terapêutica anti-hipertensiva). A maioria dos doentes iniciam a toma da medicação após a prescrição, mas poucos têm uma implementação suficiente para que a adesão seja considerada boa. Poucos doentes descontinuaram a medicação. Conclusão: Os doentes tiveram uma maior taxa de implementação à terapêutica anti-hipertensiva, mas, por outro lado, foram mais persistentes à terapêutica antidiabética oral. O padrão da adesão à terapêutica parece ser influenciado pelo doente e pela própria doença.Rede Académica das Ciências da Saúde da Lusofonia2024-03-13info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://doi.org/10.51126/revsalus.v6i1.594https://doi.org/10.51126/revsalus.v6i1.594RevSALUS - International Scientific Journal of the Academic Network of Health Sciences of Lusophone; Vol. 6 No. 1 (2024): RevSALUS - International Scientific Journal of RACSRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia; Vol. 6 Núm. 1 (2024): RevSALUS - Revista Científica Internacional da RACSRevSALUS - Revista Científica Internacional da Rede Académica das Ciências da Saúde da Lusofonia; Vol. 6 N.º 1 (2024): RevSALUS - Revista Científica Internacional da RACS2184-836X2184-486010.51126/dnsp0x19reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttps://revsalus.com/index.php/RevSALUS/article/view/594https://revsalus.com/index.php/RevSALUS/article/view/594/473Direitos de Autor (c) 2024 RevSALUS - Revista Científica Internacional da Rede Académica das Ciências da Saúde da Lusofoniainfo:eu-repo/semantics/openAccessRosu, AmaliaCoelho, AndréCamacho, PedroRosu, Amalia2024-03-17T15:01:46Zoai:ojs.pkp.sfu.ca:article/594Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T04:01:55.618470Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Assessment of medication adherence in patients with Type 2 Diabetes and arterial hypertension: medication adherence in chronic disease Avaliação da adesão à terapêutica em doentes com Diabetes Tipo 2 e hipertensão arterial: Adesão à medicação nas doenças crónicas |
title |
Assessment of medication adherence in patients with Type 2 Diabetes and arterial hypertension: medication adherence in chronic disease |
spellingShingle |
Assessment of medication adherence in patients with Type 2 Diabetes and arterial hypertension: medication adherence in chronic disease Rosu, Amalia Arterial Hypertension chronic disease initiation medication adherence persistence type 2 diabetes mellitus Hipertensão Arterial doença crónica iniciação adesão à terapêutica persistência Diabetes Mellitus tipo 2 |
title_short |
Assessment of medication adherence in patients with Type 2 Diabetes and arterial hypertension: medication adherence in chronic disease |
title_full |
Assessment of medication adherence in patients with Type 2 Diabetes and arterial hypertension: medication adherence in chronic disease |
title_fullStr |
Assessment of medication adherence in patients with Type 2 Diabetes and arterial hypertension: medication adherence in chronic disease |
title_full_unstemmed |
Assessment of medication adherence in patients with Type 2 Diabetes and arterial hypertension: medication adherence in chronic disease |
title_sort |
Assessment of medication adherence in patients with Type 2 Diabetes and arterial hypertension: medication adherence in chronic disease |
author |
Rosu, Amalia |
author_facet |
Rosu, Amalia Coelho, André Camacho, Pedro |
author_role |
author |
author2 |
Coelho, André Camacho, Pedro |
author2_role |
author author |
dc.contributor.author.fl_str_mv |
Rosu, Amalia Coelho, André Camacho, Pedro Rosu, Amalia |
dc.subject.por.fl_str_mv |
Arterial Hypertension chronic disease initiation medication adherence persistence type 2 diabetes mellitus Hipertensão Arterial doença crónica iniciação adesão à terapêutica persistência Diabetes Mellitus tipo 2 |
topic |
Arterial Hypertension chronic disease initiation medication adherence persistence type 2 diabetes mellitus Hipertensão Arterial doença crónica iniciação adesão à terapêutica persistência Diabetes Mellitus tipo 2 |
description |
Aims: Assessment of medication adherence in newly diagnostic and treated patients with Type 2 Diabetes Mellitus and Arterial Hypertension, in the Primary Health Care Units of Lisbon and Tagus Valley. Methods: This is an observational and retrospective cohort study. The population is composed of newly diagnosed patients with Type 2 Diabetes Mellitus and Arterial Hypertension, at the beginning of treatment. Data was extracted from the Lisbon and Tagus Valley Regional Health Administration Information System. Medication adherence was assessed in three periods: patients started therapy or not after the professional's prescription (initiation); medication possession rate during the follow-up period (MPR) (implementation) and medication discontinuation, marks the end of therapy (discontinuation). Results: An initiation rate of 84.2% was obtained in patients with both diseases (98% for oral antidiabetic therapy and 84.6% for antihypertensive therapy). The implementation rates (MPR) for both diseases was only 3.4% (4.2% were considered adherent to oral antidiabetic therapy and 8.5% to antihypertensive therapy). The discontinuation rate was 3.4% (5.5% for oral antidiabetic therapy and 13.2% for antihypertensive therapy). Most patients initiate taking drugs after prescription but very few patients have a MPR enough to consider them having good adherence. Moreover, few patients discontinue the medication. Conclusions: Patients had a higher implementation rate to antihypertensive therapy but, on the other hand, were more persistent to the oral antidiabetic therapy. Through this new assessment, the medication adherence pattern seems to be influenced by the patient and by the disease itself. |
publishDate |
2024 |
dc.date.none.fl_str_mv |
2024-03-13 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://doi.org/10.51126/revsalus.v6i1.594 https://doi.org/10.51126/revsalus.v6i1.594 |
url |
https://doi.org/10.51126/revsalus.v6i1.594 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://revsalus.com/index.php/RevSALUS/article/view/594 https://revsalus.com/index.php/RevSALUS/article/view/594/473 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Rede Académica das Ciências da Saúde da Lusofonia |
publisher.none.fl_str_mv |
Rede Académica das Ciências da Saúde da Lusofonia |
dc.source.none.fl_str_mv |
RevSALUS - International Scientific Journal of the Academic Network of Health Sciences of Lusophone; Vol. 6 No. 1 (2024): RevSALUS - International Scientific Journal of RACS RevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia; Vol. 6 Núm. 1 (2024): RevSALUS - Revista Científica Internacional da RACS RevSALUS - Revista Científica Internacional da Rede Académica das Ciências da Saúde da Lusofonia; Vol. 6 N.º 1 (2024): RevSALUS - Revista Científica Internacional da RACS 2184-836X 2184-4860 10.51126/dnsp0x19 reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799138191845883904 |